$复宏汉霖(0269_老虎社区_美港股上老虎

保本第一位
05-22

$复宏汉霖(02696)$最近ADC赛道真是热,复宏汉霖之前一直只听说过HLX43，今天才发现还有个双抗ADC叫HLX48。最关键是它瞄准了耐药难题，针对EGFR/c-MET双靶点，而且是在中国和澳大利亚同步开发的。看来他们的ADC平台也在不断推进新管线啊。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":566967794725480,"tweetId":"566967794725480","gmtCreate":1779441075975,"gmtModify":1779441182635,"author":{"id":4218241451199990,"idStr":"4218241451199990","authorId":4218241451199990,"authorIdStr":"4218241451199990","name":"保本第一位","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":10,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><a href=\"https://laohu8.com/S/02696\">$复宏汉霖(02696)$</a>最近ADC赛道真是热,复宏汉霖之前一直只听说过HLX43，今天才发现还有个双抗ADC叫HLX48。最关键是它瞄准了耐药难题，针对EGFR/c-MET双靶点，而且是在中国和澳大利亚同步开发的。看来他们的ADC平台也在不断推进新管线啊。</body></html>","htmlText":"<html><head></head><body><a href=\"https://laohu8.com/S/02696\">$复宏汉霖(02696)$</a>最近ADC赛道真是热,复宏汉霖之前一直只听说过HLX43，今天才发现还有个双抗ADC叫HLX48。最关键是它瞄准了耐药难题，针对EGFR/c-MET双靶点，而且是在中国和澳大利亚同步开发的。看来他们的ADC平台也在不断推进新管线啊。</body></html>","text":"$复宏汉霖(02696)$最近ADC赛道真是热,复宏汉霖之前一直只听说过HLX43，今天才发现还有个双抗ADC叫HLX48。最关键是它瞄准了耐药难题，针对EGFR/c-MET双靶点，而且是在中国和澳大利亚同步开发的。看来他们的ADC平台也在不断推进新管线啊。","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/566967794725480","repostId":0,"isVote":1,"tweetType":1,"viewCount":165,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02696"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":213,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}